Events
Vivet presenting at 6th annual Gene Therapy for Rare Disorders Europe in London
Vivet will be attending and presenting during 6th annual Gene Therapy for Rare Disorders Europe in London. “Gain European Regulatory Clarity to Progress Efficient &
Vivet presenting during 3rd annual Gene Therapy Immunogenicity Conference in Boston – Oct. 18-20 2022
Vivet will be attending and presenting during 3rd annual Gene Therapy Immunogenicity Conference in Boston. Overcoming Translational Hurdles, Improving Immunology Assays & Optimizing Clinical Strategies
Vivet presenting during next ESGCT congress in Edinburgh – Oct. 11-14, 2022
Vivet will be attending and presenting some new and exciting results from its different programs and platforms this week at the upcoming ESGCT congress in
Vivet presenting during the 1st Annual Optimizing AAV Safety Summit in Boston – Sept. 6-8, 2022
Vivet will be attending and presenting during the 1st Annual Optimizing AAV Safety Summit in Boston. With hundreds of clinical trials using AAV currently underway, it
Vivet attending 2nd Gene Patient Engagement congress in Boston – June 7-9, 2022
Vivet will be attending the 2nd Gene Patient Engagement congress with Sonia VALERO, Head of Clinical Operations and Patient Advocacy. On the agenda, very interesting
Vivet Therapeutics Announces 4 Presentations During the 2022 American Society Of Gene And Cell Therapy Annual Meeting
Vivet Therapeutics, a clinical-stage biotech company dedicated to developing gene therapy
Vivet presenting during 2022 ARM Meeting on the Med in Barcelona
Vivet Therapeutics BD Director, Thomas Daniel-Robin
VIVET ATTENDING 2021 WORLD ORPHAN DRUG CONGRESS EUROPE IN BARCELONA
Vivet Therapeutics CEO, Jean-Philippe Combal, will be participating to a panel during 2021 World Orphan Drug Congress Europe in Barcelona (Nov 15-18).
VIVET THERAPEUTICS ANNOUNCES 2 ORAL PRESENTATIONS AND 4 ABSTRACTS AT 2021 ESGCT ANNUAL MEETING
VIVET THERAPEUTICS ANNOUNCES 2 ORAL PRESENTATIONS AND 4 ABSTRACTS AT 2021 ESGCT ANNUAL MEETING
Vivet CDO, Anne Douar, presenting during SFTCG webinar on Gene Therapy for Wilson Disease
Vivet CDO, Anne Douar, will be presenting
